NCT04230265 2026-01-22Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic MalignanciesAvenCell Therapeutics, Inc.Phase 1 Terminated32 enrolled
NCT04633148 2024-04-23Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA MarkerAvenCell Therapeutics, Inc.Phase 1 Terminated16 enrolled